Fifty 1 Labs, Inc. (NWAU)
| Market Cap | 236.97K -88.8% |
| Revenue (ttm) | 47.00 -100.0% |
| Net Income | -656.25K |
| EPS | -0.00 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,000 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.0001 - 0.0001 |
| Beta | 2.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Fifty 1 Labs
Fifty 1 Labs, Inc. operates as a retailer in the used vehicle market of the United States. It focuses primarily on the buy here/pay here segment of the independent used vehicle sales and finance market. The company sells approximately 2000 and newer model-year used vehicles and provides related financing through sale type leases. As of December 31, 2010, it had two retail locations in Arizona. Fifty 1 Labs, Inc. was formerly known as Consumer Automotive Finance, Inc. and changed its name to Fifty 1 Labs, Inc. in March 2025. Fifty 1 Labs, Inc. w... [Read more]
Financial Performance
In fiscal year 2025, Fifty 1 Labs's revenue was $647, an increase of 37.66% compared to the previous year's $470. Losses were -$703,873, 10.8% more than in 2024.
Financial StatementsNews
Fifty 1 Labs, Inc. Acquires MSK Signal Recovery Product Line to Accelerate Growth in the Peptide and Musculoskeletal Health Market
Acquisition expands Fifty 1 Labs' portfolio with a five-product musculoskeletal recovery platform focused on injury recovery, rehabilitation, connective tissue support, joint health, and peptide-focus...
Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform
Model expected to include digital intake, clinician evaluation, prescription routing, monitoring coordination, and subscription-based patient support VANCOUVER, BC / ACCESS Newswire / August 7, 2026 /...
Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth
Company outlines dual platform spanning peptide R&D, AI-enabled discovery, and planned U.S. telehealth peptide services VANCOUVER, BC / ACCESS Newswire / July 10, 2026 / Fifty 1 Labs, Inc. (OTCID:FITY...
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health
AI-Enabled Discovery and Clinical-Stage Development Target Injury Recovery, Performance, and Tissue Healing VANCOUVER, BC / ACCESS Newswire / April 15, 2026 / Fifty 1 Labs, Inc. (OTC:FITY), powered by...
Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market
Company Retires 1,748,933 Series B Preferred Shares, Permanently Blocking Conversion into 612,126,550 Common Shares - Bought Back with Company Funds VANCOUVER, BC / ACCESS Newswire / April 14, 2026 / ...
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC: FITY) today issues the following clarification regarding its press release dated August 26, 2025, whi...
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research
Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.
Strategic Acquisition Bolsters AI-Driven Healthcare Innovation, Positioning Fifty 1 Labs as a Leader in Clinical Data Analytics Strategic Acquisition Bolsters AI-Driven Healthcare Innovation, Position...
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
Leadership Team's Technical Primer Enhances Real-World Evidence (RWE) for Cross-Border Impact, Positioning Fifty1 AI Labs in a $48B Market Opportunity Leadership Team's Technical Primer Enhances Real-...
Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY), has entered a groundbreaking partnership with LUNR Aerospa...
Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies
Landmark AI-driven analysis backed by The Gates Foundation sets stage for transformative treatments in one of the world's most underserved diseases Landmark AI-driven analysis backed by The Gates Foun...
Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation
Strategic partnership and planned acquisition position Fifty1 Labs to dominate AI-driven drug repurposing and wellness therapeutics at scale Strategic partnership and planned acquisition position Fift...
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY), is thrilled to announce a strategic partnership with an intent ...
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership
Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M Valuation Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformat...
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in A...
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV
MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. ( OTC: FITY), through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug discove...
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's SpaceX Fram2 Mission Advances Space-Based Biotechnology Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's Spac...
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger
Company Eliminates $800,000 in Debt and additional 930 Million Dilutive Shares, to Strengthen Foundation for Future Growth with Entirely New Management Team MIAMI , March 20, 2025 /PRNewswire/ -- 4Cab...
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
MELBOURNE, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( OTCPK: FITY), formerly Consumer Automotive Finance, Inc. (OTCPK: CAFI), a dynamic leader in the sports supplement, ...
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc.
MELBOURNE, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- via IBN – Consumer Automotive Finance, Inc. ( OTC P K: CAFI), soon to be rebranded as Fifty 1 Labs, Inc., a dynamic leader in the sports supplement,...
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change
MELBOURNE, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- 51 Labs, a wholly owned subsidiary of Fifty 1 Labs, Inc., a dynamic company active in the sports supplement, fitness equipment, and health...
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance
Company Announces Pending Name and Ticker Symbol Change to Fifty 1 Labs, Inc. (OTC: FITY) Company Announces Pending Name and Ticker Symbol Change to Fifty 1 Labs, Inc. (OTC: FITY)
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC
Company adds another patent to its portfolio with acquisition MELBOURNE, Fla. , June 18, 2024 /PRNewswire/ -- Fifty 1 Labs, Inc. (OTCPK: CAFI), a leading company in the sports supplement, sports equip...
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates
Significant Developments Including Key Management Hires, Acquisitions, and New Patent Acquisition MELBOURNE, Fla. , June 13, 2024 /PRNewswire/ -- Fifty 1 Labs, Inc. (OTCPK: CAFI), a holding company th...